Published in Clin Pharmacol Ther on July 01, 2001
Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone | NCT00504413
The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data. Curr Neuropharmacol (2008) 1.21
Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice. Psychopharmacology (Berl) (2004) 1.04
Changes to methadone clearance during pregnancy. Eur J Clin Pharmacol (2005) 1.03
Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients. Br J Clin Pharmacol (2004) 1.03
Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment. Br J Clin Pharmacol (2009) 0.98
The effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone. Br J Clin Pharmacol (2004) 0.91
Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19. Br J Clin Pharmacol (2014) 0.91
Pharmacokinetic interaction between voriconazole and methadone at steady state in patients on methadone therapy. Antimicrob Agents Chemother (2006) 0.85
Determination of the unbound fraction of R- and S-methadone in human brain. Int J Legal Med (2016) 0.84
Moving toward personalized medicine in the methadone maintenance treatment program: a pilot study on the evaluation of treatment responses in Taiwan. Biomed Res Int (2013) 0.84
Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure. Br J Clin Pharmacol (2004) 0.84
Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjects. Br J Clin Pharmacol (2005) 0.83
Fatal methadone toxicity: potential role of CYP3A4 genetic polymorphism. J Anal Toxicol (2014) 0.83
Case report: quantification of methadone-induced respiratory depression using toxicokinetic/toxicodynamic relationships. Crit Care (2007) 0.81
S-Methadone augments R-methadone induced respiratory depression in the neonatal guinea pig. Respir Physiol Neurobiol (2009) 0.78
Ethnic and genetic factors in methadone pharmacokinetics: a population pharmacokinetic study. Drug Alcohol Depend (2014) 0.76
Gender differences in pharmacokinetics and pharmacodynamics of methadone substitution therapy. Front Pharmacol (2015) 0.76
Tell-Tale SNPs: The Role of CYP2B6 in Methadone Fatalities. J Anal Toxicol (2017) 0.75
Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of methadone in a sample of Iranian (mazandarani) opiate users undergoing methadone maintenance treatment. Iran J Psychiatry Behav Sci (2011) 0.75
Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity. Br J Clin Pharmacol (2015) 0.75
The diagnostic performance of computer programs for the interpretation of electrocardiograms. N Engl J Med (1991) 3.15
Newer antidepressants and the cytochrome P450 system. Am J Psychiatry (1996) 2.90
Limited evolutionary conservation of imprinting in the human placenta. Proc Natl Acad Sci U S A (2006) 2.08
Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. Hum Mol Genet (2006) 1.63
Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther (2007) 1.56
Common standards for quantitative electrocardiography: goals and main results. CSE Working Party. Methods Inf Med (1990) 1.54
Immunofixation after electrofocusing: improved method for specific detection of serum proteins with determination of isoelectric points. I. Immunofixation print technique for detection of alpha-1-protease inhibitor. J Immunol Methods (1977) 1.39
Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults. J Clin Oncol (2004) 1.37
Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma. Bone Marrow Transplant (2002) 1.33
A reference data base for multilead electrocardiographic computer measurement programs. J Am Coll Cardiol (1987) 1.28
Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses. J Clin Psychopharmacol (1997) 1.28
Transferrin binding to peripheral blood lymphocytes activated by phytohemagglutinin involves a specific receptor. Ligand interaction. J Clin Invest (1980) 1.26
Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol. Drug Metab Dispos (2000) 1.23
Fluoxetine-related death in a child with cytochrome P-450 2D6 genetic deficiency. J Child Adolesc Psychopharmacol (2000) 1.22
Preferential transmission of the Z deficient allele of alpha 1-antitrypsin. Science (1979) 1.21
Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose. Clin Pharmacol Ther (1985) 1.20
Structural studies of T lymphocyte Fc receptors. Association of Gc protein with IgG binding to Fc gamma. J Biol Chem (1985) 1.17
Disposition and pharmacodynamics of methamphetamine in pregnant sheep. JAMA (1991) 1.16
Gc (vitamin D binding protein) binds to cytoplasm of all human lymphocytes and is expressed on B-cell membranes. Clin Immunol Immunopathol (1984) 1.10
A general method for fractionation of plasma proteins. Dye-ligand affinity chromatography on immobilized Cibacron blue F3-GA. Biochem J (1982) 1.09
Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation. Brain (2007) 1.09
The synthesis of human alpha-2-HS glycoprotein is down-regulated by cytokines in hepatoma HepG2 cells. FEBS Lett (1988) 1.08
Increased frequency of the MZ phenotype of alpha-1-protease inhibitor in juvenile chronic polyarthritis. J Clin Invest (1977) 1.05
Development of vegetable extracts by microencapsulation. J Microencapsul (1998) 1.04
Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression. J Clin Pharmacol (1995) 1.02
Comparison of cytologic and genetic distances between long arm subtelomeric markers of human autosome 14 suggests uneven distribution of crossing-over. Cytogenet Cell Genet (1987) 1.02
Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. Life Sci (2000) 1.00
Evidence of increased Gc:actin complexes in pregnant serum: a possible result of trophoblast embolism. Am J Reprod Immunol (1983) 0.99
A new allele of human alpha1-antitrypsin: PiNhampton. Am J Hum Genet (1978) 0.98
Abnormal regulation of IgG production in multiple sclerosis. Neurology (1982) 0.98
Dose escalation with pharmacokinetics monitoring in methotrexate chemotherapy of osteosarcoma. Anticancer Res (1995) 0.97
Drug glucuronidation in clinical psychopharmacology. J Clin Psychopharmacol (2001) 0.95
Human recombinant alpha 2-HS glycoprotein is produced in insect cells as a full length inhibitor of the insulin receptor tyrosine kinase. Horm Metab Res (1998) 0.95
Dosage regimen design. Pharmacol Ther (1982) 0.95
Improved thermostability of the North American firefly luciferase: saturation mutagenesis at position 354. Biochem J (1996) 0.95
Modulation of the immune response by plasma protease inhibitors. I. Alpha 2-macroglobulin and alpha 1-antitrypsin inhibit natural killing and antibody-dependent cell-mediated cytotoxicity. Scand J Immunol (1982) 0.95
Panic disorder. Recognizing and managing the 'real thing'. Postgrad Med (1992) 0.94
Chromatography of plasma proteins on immobilized Cibacron Blue F3-GA. Mechanism of the molecular interaction. Biochem J (1982) 0.94
In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions. Int J Pharm (2001) 0.94
Rifampin-induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertraline. J Clin Psychopharmacol (2000) 0.93
Apparent total alpha1-antitrypsin deficiency: report of a case. Isr J Med Sci (1976) 0.93
Decreased serum group-specific component protein levels and complexes with actin in fulminant hepatic necrosis. Hepatology (1985) 0.92
Partial hepatectomy and mediators of inflammation decrease the expression of liver alpha 2-HS glycoprotein gene in rats. FEBS Lett (1990) 0.92
Assessment of the performance of electrocardiographic computer programs with the use of a reference data base. Circulation (1985) 0.90
Stability of bupropion and its major metabolites in human plasma. Ther Drug Monit (1985) 0.90
Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuation. J Clin Psychopharmacol (1991) 0.89
Distinct sites on the G-actin molecule bind group-specific component and deoxyribonuclease I. Biochem J (1985) 0.89
Inhibition of Entamoeba histolytica cytotoxin by alpha 1 antiprotease and alpha 2 macroglobulin. Am J Trop Med Hyg (1981) 0.89
Alpha-1-antitrypsin (Pi) types in Down's syndrome. Clin Genet (1976) 0.88
HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer. J Pharm Sci (2001) 0.88
Fractionation and characterization of the immunosuppressive substance in crude extracellular products released by Streptococcus intermedius. J Clin Invest (1981) 0.88
[Hyperosmolar coma in diabetics. II. Physiopathology, diagnostic and therapeutic deductions]. Presse Med (1971) 0.88
Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome. J Clin Oncol (2001) 0.88
Evaluation of ECG interpretation results obtained by computer and cardiologists. Methods Inf Med (1990) 0.87
S1 SINE retroposons are methylated at symmetrical and non-symmetrical positions in Brassica napus: identification of a preferred target site for asymmetrical methylation. Plant Mol Biol (1999) 0.87
Alpha-1-antitrypsin phenotypes in Lyon, France. Hum Genet (1977) 0.87
A transcriptional analysis of the S1Bn (Brassica napus) family of SINE retroposons. Plant Mol Biol (1996) 0.87
A pharmacokinetic drug-drug interaction study of venlafaxine and indinavir. Psychopharmacol Bull (2001) 0.86
Alopecia and mood stabilizer therapy. Ann Clin Psychiatry (1996) 0.86
Microencapsulation of lipophilic drugs in chitosan-coated alginate microspheres. Int J Pharm (1999) 0.86
[Electrophysiological study of 2 cases of ventricular pre-excitation compatible with the presence of Mahaim's fibers]. Arch Mal Coeur Vaiss (1975) 0.86
Diurnal variation of alpha 1-acid glycoprotein concentration in normal volunteers. J Pharm Sci (1985) 0.86
Alpha 1-acid glycoprotein. Methods Enzymol (1988) 0.85
[Polymorphism of plasma alpha 1 antitrypsin (Pi system). Demonstration by electrofocusing on polyacrylamide gel]. C R Seances Soc Biol Fil (1974) 0.85
Gamma heavy chain disease protein CHA: immunological and structural studies. Mol Immunol (1981) 0.85
Mirtazapine in major depression with comorbid generalized anxiety disorder. J Clin Psychiatry (1999) 0.85
alpha-1-antitrypsin (Pi) phenotypes in a Finnish population. Scand J Clin Lab Invest (1977) 0.85
High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL). Leukemia (2006) 0.84
A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction. Int J Cardiol (2001) 0.84
Immunologic effects of cocaine and related alkaloids. Immunopharmacol Immunotoxicol (1991) 0.84
Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophrenia. J Clin Psychopharmacol (2000) 0.84
Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma. Bone Marrow Transplant (2002) 0.83
Autoimmune thrombocytopenic purpura after autologous stem cell transplantation. Bone Marrow Transplant (2003) 0.83
Ceruloplasmin. Methods Enzymol (1988) 0.83
Stability of computer ECG amplitude measurements in the presence of noise. The CSE Working Party. Comput Biomed Res (1990) 0.83
Desipramine and 2-hydroxy-desipramine pharmacokinetics in normal volunteers. Eur J Clin Pharmacol (1981) 0.83
Stability assessment of ketoconazole in aqueous formulations. Int J Pharm (2000) 0.83
Molecular cloning and sequence analysis of the cDNA encoding human apolipoprotein H (beta 2-glycoprotein I). Int J Clin Lab Res (1992) 0.83
The assessment and clinical implications of haloperidol acute-dose, steady-state, and withdrawal pharmacokinetics. J Clin Psychopharmacol (1993) 0.83
High frequency of deficient Pi phenotypes of alpha-1-antitrypsin in nonatopic infantile asthma. Trans Assoc Am Physicians (1976) 0.82
The human hepatoma Hep3B cell line as an experimental model in the study of the long-term regulation of acute-phase proteins by cytokines. Biochem J (1992) 0.82
Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation. Leuk Lymphoma (2005) 0.82
Transvesicoscopic Cohen ureteric reimplantation for vesicoureteral reflux in children: a single-centre 5-year experience. J Pediatr Urol (2009) 0.82
Testing the performance of ECG computer programs: the CSE diagnostic pilot study. J Electrocardiol (1987) 0.81
Oligoclonal "fingerprint" of CSF IgG in multiple sclerosis patients is not modified following intrathecal administration of natural beta-interferon. J Neurol Neurosurg Psychiatry (1986) 0.81
[Prevention of the respiratory distress syndrome of the newborn. Value of antepartum treatment with glucocorticoids]. Nouv Presse Med (1974) 0.81
Alpha-I-antitrypsin (Pi) phenotypes in Lyon, France: departure from Hardy-Weinberg equilibrium. Clin Genet (1977) 0.81
Prescribing attitudes of different physician groups regarding fluoxetine. Ann Pharmacother (1993) 0.81
[Use of moxifloxacin in tuberculosis regimen in a French teaching hospital]. Med Mal Infect (2010) 0.81
Neurointermediate pituitary lobe cells synthesize and release interleukin-6 in vitro: effects of lipopolysaccharide and interleukin-1 beta. Endocrinology (1994) 0.81
A primer on caffeine pharmacology and its drug interactions in clinical psychopharmacology. Psychopharmacol Bull (2001) 0.81
Influence of noise on wave boundary recognition by ECG measurement programs. Recommendations for preprocessing. Comput Biomed Res (1987) 0.80
The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum). Psychopharmacol Bull (2001) 0.80
Comparative affinity of the major genetic variants of human group-specific component (vitamin D-binding protein) for 25-(OH) vitamin D. J Steroid Biochem (1989) 0.80
Cerebral and blood pharmacokinetics of imipramine and its active metabolites in the pregnant rat. Psychopharmacology (Berl) (1984) 0.80
Suspected ciprofloxacin inhibition of olanzapine resulting in increased plasma concentration. J Clin Psychopharmacol (1999) 0.80
Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design. J Clin Psychiatry (1997) 0.80
Pharmacokinetics of clozapine and risperidone: a review of recent literature. J Clin Psychopharmacol (1996) 0.80
Interaction of group-specific component (vitamin D-binding protein) with immobilized Cibacron blue F3-GA. Biochim Biophys Acta (1982) 0.80